Trial Profile
Fotemustine and Dacarbazine Versus Dacarbazine +/- Alpha Interferon in Advanced Malignant Melanoma: Phase III Study.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Nov 2020
Price :
$35
*
At a glance
- Drugs Interferon alpha-2b (Primary) ; Dacarbazine; Fotemustine
- Indications Malignant melanoma
- Focus Therapeutic Use
- 24 May 2011 Additional lead trial centres and investigators identified as reported by ClinicalTrials.gov.
- 24 May 2011 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health).
- 01 Feb 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.